Compound Detail
CHEMBL4873398
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
C[C@]12CC[C@H]3[C@@H](CC[C@@]45O[C@@H]4CCC[C@]35C)[C@@H]1CC/C2=N\O
Basic Information
| ChEMBL ID | CHEMBL4873398 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | FWXZOJLFUWLDQP-QQBCYPGXSA-N |
2
Targets
2
Activities
1
Assay Types
0
PK Parameters
4
Publications
0
Known Names
Molecular Properties
303.4
MW (Da)
4.38
ALogP
3
HBA
1
HBD
45.1
PSA (Ų)
0.41
QED
0
Ro5 Violations
0
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 4.28
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| HepG2 | IC50 | = | 52700.0 | nM | 4.28 | Anticancer activity against human HepG2 cells assessed as inhibition of cell pro... | 34425478 |
| WiDr | IC50 | = | 53400.0 | nM | 4.27 | Anticancer activity against human WiDr cells assessed as inhibition of cell prol... | 34425478 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 34425478 | 10.1016/j.bmc.2021.116360 | PC-3 | 1 |
| 34425478 | 10.1016/j.bmc.2021.116360 | WiDr | 1 |
| 34425478 | 10.1016/j.bmc.2021.116360 | NCI-H1299 | 1 |
| 34425478 | 10.1016/j.bmc.2021.116360 | HepG2 | 1 |
Data from ChEMBL 36 via Core Engine